Total Payments
$4,463
2024 Payments
$134.80
Companies
21
Transactions
75
Medicare Patients
758
Medicare Billing
$70,376
Payment Breakdown by Category
Food & Beverage$4,338 (97.2%)
Other$124.99 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,338 | 74 | 97.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $124.99 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $897.54 | 23 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $537.32 | 8 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $476.15 | 9 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $406.55 | 5 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $384.62 | 4 | $0 (2022) |
| Novo Nordisk Inc | $268.03 | 6 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $266.37 | 4 | $0 (2021) |
| Silk Road Medical, Inc. | $135.26 | 1 | $0 (2023) |
| Amneal Pharmaceuticals LLC | $124.99 | 1 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $124.99 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134.80 | 3 | Solventum Corporation ($96.45) |
| 2023 | $547.20 | 5 | Silk Road Medical, Inc. ($135.26) |
| 2022 | $1,311 | 23 | ABBVIE INC. ($300.61) |
| 2021 | $2,469 | 44 | AbbVie Inc. ($495.43) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/04/2024 | Solventum Corporation | ACTIV.A.C. (Device), PROMOGRAN PRISMA | Food and Beverage | Cash or cash equivalent | $96.45 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 05/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Neuropsychiatry | ||||||
| 09/12/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTIBIOTIC | ||||||
| 06/06/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $101.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2023 | Silk Road Medical, Inc. | ENROUTE Transcarotid Neuroprotection System (Device), ENROUTE Transcarotid Stent | Food and Beverage | In-kind items and services | $135.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $112.79 | General |
| 03/22/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $72.66 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 10/13/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | In-kind items and services | $110.95 | General |
| Category: Migraine | ||||||
| 08/16/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: Obesity | ||||||
| 08/16/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $1.41 | General |
| Category: Obesity | ||||||
| 08/09/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/04/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $2.99 | General |
| Category: Obesity | ||||||
| 07/12/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/24/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $76.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2022 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $124.99 | General |
| Category: NEUROLOGY | ||||||
| 04/20/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 04/12/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PRIMARY CARE | ||||||
| 04/01/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
| 03/11/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 173 | 356 | $47,388 | $20,954 |
| 2022 | 6 | 170 | 242 | $40,990 | $13,905 |
| 2021 | 8 | 290 | 362 | $62,604 | $23,849 |
| 2020 | 6 | 125 | 159 | $34,541 | $11,668 |
Total Patients
758
Total Services
1,119
Medicare Billing
$70,376
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 32 | 112 | $15,344 | $7,056 | 46.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 33 | 60 | $8,220 | $3,780 | 46.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 38 | 77 | $8,008 | $3,380 | 42.2% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 24 | 33 | $5,775 | $2,914 | 50.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 40 | $5,680 | $1,826 | 32.1% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 15 | 15 | $2,385 | $1,164 | 48.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 12 | 19 | $1,976 | $833.91 | 42.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 107 | $15,194 | $4,866 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 57 | $5,415 | $2,330 | 43.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 18 | $7,164 | $2,273 | 31.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 13 | 13 | $5,200 | $1,793 | 34.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 18 | 22 | $4,642 | $1,521 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 25 | $3,375 | $1,122 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 52 | 52 | $15,600 | $5,821 | 37.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 102 | $9,690 | $5,034 | 52.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 59 | $7,965 | $4,010 | 50.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 39 | 76 | $10,792 | $3,437 | 31.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 25 | 25 | $9,950 | $3,237 | 32.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 17 | 17 | $3,587 | $1,146 | 31.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $4,250 | $776.18 | 18.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 14 | $770.00 | $388.27 | 50.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 32 | 32 | $8,000 | $3,089 | 38.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 27 | 42 | $8,582 | $2,907 | 33.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 41 | $5,822 | $1,956 | 33.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 14 | $5,584 | $1,872 | 33.5% |
About Allison Van Den Brand, FNP
Allison Van Den Brand, FNP is a Family healthcare provider based in West Amherst, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2018. The National Provider Identifier (NPI) number assigned to this provider is 1679059455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Allison Van Den Brand, FNP has received a total of $4,463 in payments from pharmaceutical and medical device companies, with $134.80 received in 2024. These payments were reported across 75 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,338).
As a Medicare-enrolled provider, Van Den Brand has provided services to 758 Medicare beneficiaries, totaling 1,119 services with total Medicare billing of $70,376. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location West Amherst, NY
- Active Since 07/16/2018
- Last Updated 01/30/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1679059455
Products in Payments
- UBRELVY (Drug) $681.62
- XARELTO (Drug) $476.15
- NURTEC ODT (Drug) $391.36
- FARXIGA (Drug) $282.23
- SOLIQUA 100/33 (Biological) $259.62
- OFEV (Drug) $249.97
- ENROUTE Transcarotid Neuroprotection System (Device) $135.26
- Saxenda (Drug) $131.77
- TOUJEO (Biological) $125.00
- AUSTEDO (Drug) $124.99
- NUZYRA (Drug) $124.99
- RYBELSUS (Drug) $124.99
- RYTARY (Drug) $124.99
- BREZTRI (Drug) $124.32
- Trudhesa (Drug) $110.95
- NEXLIZET (Drug) $104.82
- QULIPTA (Drug) $101.50
- Epclusa (Drug) $100.00
- ACTIV.A.C. (Device) $96.45
- NUPLAZID (Drug) $87.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.